Middle EAST End Stage Renal Disease Industry Growth Report: Key Drivers and Strategic Insights
The Middle EAST End Stage Renal Disease Market was valued at USD 2.5 billion in 2024 and is projected to reach USD 5.1 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several key factors, including an increasing prevalence of chronic kidney diseases, advancements in renal replacement therapies, and a rising awareness of kidney health among the population....
0 Commentarios 0 Acciones 361 Views 0 Vista previa